Lumos Diagnostics Holdings (ASX:LDX) Cash-to-Debt : 0.16 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Lumos Diagnostics Holdings's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.16.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Lumos Diagnostics Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Lumos Diagnostics Holdings's Cash-to-Debt or its related term are showing as below:

ASX:LDX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.16 Med: 0.71 Max: 9.02
Current: 0.16

During the past 2 years, Lumos Diagnostics Holdings's highest Cash to Debt Ratio was 9.02. The lowest was 0.16. And the median was 0.71.

ASX:LDX's Cash-to-Debt is ranked worse than
85.31% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.32 vs ASX:LDX: 0.16

Lumos Diagnostics Holdings Cash-to-Debt Historical Data

The historical data trend for Lumos Diagnostics Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Lumos Diagnostics Holdings Cash-to-Debt Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Cash-to-Debt

1.11

0.31

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			1.29	1.11	0.16	0.31	0.16

Competitive Comparison of Lumos Diagnostics Holdings's Cash-to-Debt

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Cash-to-Debt falls into.

Lumos Diagnostics Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Lumos Diagnostics Holdings's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.492	/	(3.037	+	11.543)
	=	0.31

Lumos Diagnostics Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.06	/	(1.354	+	11.386)
	=	0.16

Lumos Diagnostics Holdings (ASX:LDX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Lumos Diagnostics Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines